Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Addpharma Inc.
Condition or disease : hypertension Intervention/treatment Drug : AD-209-H Drug : AD-209-M Drug : AD-209-L Drug : Placebo Drug : Amlodipine Drug : Telmisartan Phase : Phase 2
Age
19–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent
Other inclusions applied
You may not be if
orthostatic hypotension with symptom
Other exclusions applied
Clareo Health | Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension
